The Chinese University of Hong Kong Early Arthritis Study

NCT00901550 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate
DRUG: Infliximab

Sponsor

Chinese University of Hong Kong